As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

RAYMOND DWEK, a director at $UTHR, sold 3,000 shares of the company on 04-14-2025 for an estimated $855,480. We received data on the trade from a recent SEC filing ...

Liquidia's collaboration with Sandoz and development of new products like L606 show promise. Learn why LQDA stock is a Hold.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

It is worth considering United Therapeutics (UTHR), which belongs to the Zacks Medical - Drugs industry. This drugmaker has an established record of topping earnings estimates, especially when ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on United Therapeutics (UTHR – Research ...

In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against other most expensive stocks insiders are dumping in March. After being in the green ...

A month has gone by since the last earnings report for United Therapeutics (UTHR). Shares have lost about 4.8% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...

Shares of UTHR stock opened at $310.82 on Thursday. United Therapeutics Co. has a 1 year low of $221.53 and a 1 year high of $417.82. The business’s fifty day moving average is $342.26 and its ...